Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > ICHOR blood services
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(445)
•••
Comment by Liked2Thinkon Oct 26, 2022 10:38am
88 Views
Post# 35049566

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ICHOR blood services

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ICHOR blood servicesDude, you cant argue with stupid.

These guys
1.are pumping a company that has LOST 99% of its value since releasing its "premium" product

2. dont care Tripp said there would be $30M in revenue then produced a couple hundred grand.

3. dont care that Oncore and iBodyCheck was actually touted as something

4. dont care they lied to the number of covid tests they would be doing by using the word "capacity" - remember all those spreadsheet numbers based on tests, where did that loser go.

5. dont care that stage is constantly either late or reports the last possible second results even though they have f all to track 

6. dont care that stage will never report accurate number of any tests

7. dont care that even after telling investors f all, stage comes out and says they will tell them even less


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities